1 no longer available, 1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Sonescence, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 Randomized Study to Compare Ultrasonic Drug Delivery to Standard of Care for the Treatment of Infections in Non-Healing Wounds Ultrasonic Drug Delivery, Standard of Care Antibiotic Treatment - Acute Bacterial Skin and Skin Structure Infection (ABSSSI), Non-healing Wound | Phase 2 | Unknown | Sonescence, Inc. | 30 | 2019-02-01 | 2018-11-06 |
| Direct Antibiotic Delivery of Cefazolin Into Soft Tissue Infections Using Subcutaneous Injection and Ultrasonic Dispersion Cefazolin, Silberg Tissue Preparation System - Infection, Soft Tissue, Infection, Wound | No longer available | Sonescence, Inc. | 2018-10-23 |
Cellulitis (1) · Diabetes Mellitus (1) · Diabetic Foot (1) · Foot Ulcer (1) · Soft Tissue Infections (1) · Wound Infection (1)
Cefazolin (2)
United States (1)
Barry N Silberg, MD (1) · David G Armstrong, Ph.D., DPM (1) · James K Gude, MD (1)